Metalloendopeptidase ADAM-like Decysin 1 (ADAMDEC1) in Colonic Subepithelial PDGFRα+ Cells Is a New Marker for Inflammatory Bowel Disease

by Baek, G., Bartlett, A., Becker, L., Choi, S.-C, Gottfried-Blackmore, A., Ha, S.E, Habtezion, A., Jin, B., Jorgensen, B.G, Kim, M.-S, Kim, S., Kim, Y.-S, Kurahashi, M., Lee, M.-Y, Poudrier, S.M, Ro, S., Rubin, S.J.S, Sanders, K.M, Sasse, K.C, Singh, R., Wei, L., Zogg, H.
Published 2022

Blockchain Enabled Patient-Centred Care for Inflammatory Bowel Disease: 4 Principles for Socio-Techical and Clinical Alignment

by Hollingsworth, L., Wong, M.C, Yee, K.C
Published 2022

Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment

by Elsea, S.H, Grimes, A.B, Karam, L.B, Karsenty, C.L, Liu, N., Rawls-Castillo, B.L, Soler-Alfonso, C., Sutton, V.R, Tallis, E.
Published 2022

Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists

by Bardi, M., Chan, J., Choquette, D., Sihota, A., Smith, B.K, Torani, G., Whiskin, C.
Published 2021

Sodium-glucose cotransporter type 2 channel inhibitor: Breakthrough in the treatment of neutropenia in patients with glycogen storage disease type 1b?

by Ciara, E., Ehmke vel Emczyńska-Seliga, E., Greczan, M., Kaczor, M., Kierus, K., Książyk, J., Piątosa, B., Rokicki, D., Wesół-Kucharska, D.
Published 2022

A Systematic Review of Monogenic Inflammatory Bowel Disease

by Cho, J., Griffiths, A.M, Iwama, I., Klein, C., Kotlarz, D., McGovern, D.P.B, Muise, A.M, Mulder, D.J, Nambu, R., Snapper, S.B, Warner, N.
Published 2022

Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis

by Allegretti, J.R, Baniecki, M.L, Chandra, D.E, Danese, S., Hassan-Zahraee, M., Hung, K.E, Hyde, C.L, Karlsson, F., Klopocka, M., Lepsy, C., Li, X., Longman, R., Neelakantan, S., Quan, J., Raha, N., Romatowski, J., Scherl, E.J, Schoenbeck, U., Vincent, M.S, Xi, L., Ye, Z., Zhang, J., Ziemek, D.
Published 2022

Besca, a single-cell transcriptomics analysis toolkit to accelerate translational research

by Badi, L., Ebeling, M., Hatje, K., Julien-Laferriere, A., Kam-Thong, T., Kang, A.S.W, Mädler, S.C, Phan, M., Schmucki, R., Schwalie, P.C, Sonrel, A., Ulrich, E., Wyss, L., Zhang, J.D
Published 2021

The Fecal Microbiome and Metabolome of Pitt Hopkins Syndrome, a Severe Autism Spectrum Disorder

by Adams, J.B, Dilmore, A.H, Dorrestein, P.C, Elijah, E., Knight, R., Krajmalnik-Brown, R., McDonald, D., Nguyen, T.T
Published 2021

Metabolic modelling reveals broad changes in gut microbial metabolism in inflammatory bowel disease patients with dysbiosis

by Heinken, A., Hertel, J., Thiele, I.
Published 2021

Multivariable association discovery in population-scale meta-omics studies

by Bravo, H.C, Chatterjee, S., Franzosa, E.A, Huttenhower, C., Lu, Y., Ma, S., Mallick, H., McIver, L.J, Nguyen, L.H, Paulson, J.N, Rahnavard, A., Ren, B., Schwager, E.H, Subramanian, A., Thompson, K.N, Tickle, T.L, Waldron, L., Weingart, G., Wilkinson, J.E, Zhang, Y.
Published 2021

Identification of Cytochrome b-245, beta-chain gene mutations, and clinical presentations in Iranian patients with X-linked chronic granulomatous disease

by Abolnezhadian, F., Ghadiri, A.A, Ghandil, P., Heydari, A., Saberi, A., Sadeghi-Shabestari, M., Shamsizadeh, A.
Published 2021

Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level Data

by Attauabi, M., Burisch, J., Dahlerup, J.F, Eraslan, S., Glerup, H., Haderslev, K.V, Hansen, M.R, Jensen, M.D, Jess, T., Kiszka-Kanowitz, M., Larsen, L., Lødrup, A.B, Molazahi, A., Neumann, A., Oppfeldt, A.M, Pedersen, N., Poulsen, A., Prahm, A.P, Seidelin, J.B, Theede, K., Vester-Andersen, M.K
Published 2022

Ulcerative colitis as a possible sequela of COVID-19 Infection: The endless story

by El Kassas, M., Elbadry, M., Medhat, M.A, Zaky, S.
Published 2022

A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis

by Gao, C., He, C., Li, L., Pan, Y., Yang, X., Zhang, Y., Zhou, Z.
Published 2022

Impact of Cannabis Use on Inpatient Inflammatory Bowel Disease Outcomes in 2 States Legalizing Recreational Cannabis

by Afzali, A., Anaizi, A., Hinton, A., Lara, L., Nemer, L., Pusateri, A.
Published 2022

Effectiveness of disease-specific cognitive behavioral therapy on anxiety, depression, and quality of life in youth with inflammatory bowel disease: A randomized controlled trial

by Beukers, R., Escher, J.C, Hillegers, M.H.J, Korpershoek, T.A, Stapersma, L., Szigethy, E.M, Theuns-Valks, S.D.M, Utens, E.M.W.J, Van Den Brink, G., Van Der Ende, J.
Published 2018

Trpnet: Understanding tryptophan metabolism across gut microbiome

by Chalifour, L., Chammas, J.-B, Chong, J., Lu, Y., Shen, S., Xia, J.
Published 2022

The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults with Inflammatory Bowel Diseases and Cirrhosis

by Kochar, B., Lai, J.C, Ritchie, C.S, Ufere, N.N
Published 2022

The efficacy of immunomodulators in the prevention and suppression of anti-drug antibodies to anti-tumor necrosis factor therapy in inflammatory bowel disease

by Albani, E.N, Christodoulou, D.K, Fousekis, F.S, Katsanos, K.H, Kourtis, G., Orfanidou, A., Papamichael, K., Saridi, M.
Published 2022